Metabolic Alterations Underlying Bevacizumab Therapy in Glioblastoma Cells
Oncotarget - United States
doi 10.18632/oncotarget.21761
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 11, 2017
Authors
Publisher
Impact Journals, LLC